Taiwan · Delayed Price · Currency is TWD EirGenix Statistics
Total Valuation
EirGenix has a market cap or net worth of TWD 13.59 billion. The enterprise value is 11.85 billion.
| Market Cap | 13.59B |
| Enterprise Value | 11.85B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EirGenix has 302.65 million shares outstanding. The number of shares has decreased by -0.87% in one year.
| Current Share Class | 302.65M |
| Shares Outstanding | 302.65M |
| Shares Change (YoY) | -0.87% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 1.44% |
| Owned by Institutions (%) | 7.81% |
| Float | 193.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.01 |
| PB Ratio | 1.66 |
| P/TBV Ratio | 1.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 29.06 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.89 |
| EV / Sales | 10.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -35.53 |
Financial Position
The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.19.
| Current Ratio | 4.60 |
| Quick Ratio | 3.93 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.55 |
| Interest Coverage | -92.43 |
Financial Efficiency
Return on equity (ROE) is -8.74% and return on invested capital (ROIC) is -12.18%.
| Return on Equity (ROE) | -8.74% |
| Return on Assets (ROA) | -4.62% |
| Return on Invested Capital (ROIC) | -12.18% |
| Return on Capital Employed (ROCE) | -8.15% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | 1.13M |
| Profits Per Employee | -745,700 |
| Employee Count | 1,000 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 1.59 |
Taxes
In the past 12 months, EirGenix has paid 638,000 in taxes.
| Income Tax | 638,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.46% in the last 52 weeks. The beta is 0.41, so EirGenix's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -27.46% |
| 50-Day Moving Average | 48.07 |
| 200-Day Moving Average | 60.77 |
| Relative Strength Index (RSI) | 50.50 |
| Average Volume (20 Days) | 1,625,934 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EirGenix had revenue of TWD 1.13 billion and -745.70 million in losses. Loss per share was -2.46.
| Revenue | 1.13B |
| Gross Profit | 241.63M |
| Operating Income | -791.01M |
| Pretax Income | -745.06M |
| Net Income | -745.70M |
| EBITDA | -574.34M |
| EBIT | -791.01M |
| Loss Per Share | -2.46 |
Balance Sheet
The company has 3.26 billion in cash and 1.52 billion in debt, with a net cash position of 1.74 billion or 5.74 per share.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 1.52B |
| Net Cash | 1.74B |
| Net Cash Per Share | 5.74 |
| Equity (Book Value) | 8.21B |
| Book Value Per Share | 27.11 |
| Working Capital | 3.28B |
Cash Flow
In the last 12 months, operating cash flow was 467.56 million and capital expenditures -801.13 million, giving a free cash flow of -333.56 million.
| Operating Cash Flow | 467.56M |
| Capital Expenditures | -801.13M |
| Depreciation & Amortization | 216.68M |
| Net Borrowing | 285.35M |
| Free Cash Flow | -333.56M |
| FCF Per Share | -1.10 |
Margins
Gross margin is 21.35%, with operating and profit margins of -69.90% and -65.89%.
| Gross Margin | 21.35% |
| Operating Margin | -69.90% |
| Pretax Margin | -65.84% |
| Profit Margin | -65.89% |
| EBITDA Margin | -50.75% |
| EBIT Margin | -69.90% |
| FCF Margin | n/a |
Dividends & Yields
EirGenix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.87% |
| Shareholder Yield | 0.87% |
| Earnings Yield | -5.49% |
| FCF Yield | -2.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |